CIBMTR research database for transplant and bone marrow injury patients
Part of Blood & lymphatic, Cancer clinical trials.
This study collects health and treatment information in a large research database. It may help researchers better understand outcomes after blood stem cell transplants or bone marrow injury from treatment like radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be treated at a CIBMTR center and have had a related, unrelated, or your own (autologous) stem cell transplant.
- You can also join if you are treated for a bone-marrow (marrow) injury at an NMDP Radiation Injury Transplant Network center.
- Being able to decide for yourself is not required—adults with or without decision-making ability and children can be included.
- If you had supportive care only, growth factor shots, a stem cell transplant, or other care for marrow injury, you may still be included.
- If you are a donor: you must be registered with the NMDP registry and have been requested to donate for a patient.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a library of transplant and related medical samples to help scientists learn how to improve cell therapies and care for marrow injury. You may be included because you are a donor, receive a transplant or cell therapy, or are treated for marrow toxic injury at participating centers.
This trial is a registry that follows children and young adults up to age 26 who are having a bone marrow transplant, to better understand complications related to blood vessel and organ injury. It may help future patients by improving how doctors predict and prevent these problems.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
This study collects medical information from people with certain non-cancer conditions who receive a stem cell transplant. It may help doctors better understand transplant outcomes and care, since the study focuses on data collection rather than adding new treatment.
This study aims to collect, store, and share data from patients who are receiving standard intensive treatment and a stem cell transplant from either their own cells or a donor. It may help improve how future patients are treated by building a reliable record of outcomes and care patterns.
This study creates a record of people who are eligible to receive a stem cell (blood-forming cell) transplant. It helps researchers learn about transplant patients and outcomes over time.
Hear when a new Autologous Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.